Liu Yan-Li, Yan Ling-Di, Zhou Pei-Lan, Wu Chun-Fu, Gong Ze-Hui
College of Pharmacy, Soochow University, Suzhou, China.
Eur J Pharmacol. 2009 Jan 14;602(2-3):321-7. doi: 10.1016/j.ejphar.2008.11.031. Epub 2008 Nov 25.
Levo-tetrahydropalmatine (l-THP) is an alkaloid purified from the Chinese herb corydalis and stephania and is contained in many traditional Chinese herbal preparations. Our previous studies demonstrated the ability of l-THP to inhibit locomotor stimulation and physical dependence induced by oxycodone in mice and rats. The present study was designed to evaluate effects of l-THP on reward of oxycodone using conditioned place preference assay. Oxycodone (0.32-5.0 mg/kg) induced the development of conditioned place preference in rats. Furthermore, oxycodone (2.5 mg/kg) induced the increased phosphorylation of CREB and ERK in nucleus accumbens and hippocampus, but not in prefrontal cortex. l-THP (6.25-18.50 mg/kg) per se was not able to induce conditioned place preference or conditioned place aversion. l-THP co-administered with oxycodone during the conditioning sessions partly abolished the development of oxycodone-induced conditioned place preference in rats. Furthermore, l-THP inhibited the increased phosphorylation of ERK and CREB in nucleus accumbens and hippocampus of rats. All these results suggest that l-THP can inhibit oxycodone-induced psychological dependence by affecting phosphorylation of CREB and ERK in nucleus accumbens and hippocampus of rats. Together, the present data, combined with previous finding, support the potential use of l-THP for treatment of oxycodone addiction.
左旋四氢巴马汀(l-THP)是从中药延胡索和防己中提纯的一种生物碱,存在于多种传统中药制剂中。我们之前的研究表明,l-THP能够抑制小鼠和大鼠中由羟考酮诱导的运动兴奋和身体依赖性。本研究旨在使用条件性位置偏爱试验评估l-THP对羟考酮奖赏作用的影响。羟考酮(0.32 - 5.0 mg/kg)可诱导大鼠产生条件性位置偏爱。此外,羟考酮(2.5 mg/kg)可诱导伏隔核和海马中CREB和ERK磷酸化增加,但在前额叶皮质中未出现这种情况。l-THP(6.25 - 18.50 mg/kg)本身不能诱导条件性位置偏爱或条件性位置厌恶。在条件训练期间,l-THP与羟考酮共同给药可部分消除大鼠中由羟考酮诱导的条件性位置偏爱的形成。此外,l-THP可抑制大鼠伏隔核和海马中ERK和CREB磷酸化的增加。所有这些结果表明,l-THP可通过影响大鼠伏隔核和海马中CREB和ERK的磷酸化来抑制羟考酮诱导的心理依赖性。总之,目前的数据与之前的研究结果相结合,支持l-THP在治疗羟考酮成瘾方面的潜在应用。